Recent studies have found that miR-145 functions as a tumor suppressor and that miR-145 overexpression suppresses migration and invasion in prostate cancer and bladder cancer by targeting FSCN1 [19, 20]. The gene discussed is FSCN1; the disease is neoplasm.